ArticleJournal of anesthesia, analgesia and critical care2025

Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections.

Milo Gatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.